ClinicalTrials.gg
RecruitingNCT07105657Rehab-hip-kneeUpdated Aug 26, 2025

The Outcome of Three Weeks Rehabilitation in Patients With a Total Hip or Knee Replacement Experiencing Persistent Physical Impairments

An observational study in Hip Osteoarthritis and Knee Osteoarthristis, sponsored by Horsens Hospital. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-26.

Sponsored by Horsens Hospital · Observational

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
84
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Osteoarthritis, Hip with a site in Denmark — 2 open to participants now, 9 under way, none of them phase 3. Osteoarthritis, Hip · Denmark.

Started
2025
the only one that year
Observational
6 of 34
2 open now
Registered
34th of 34
by date
Lead sponsor
1 of 34
Horsens Hospital

Among the 34 studies in Osteoarthritis, Hip with a site in Denmark, this one is the only one that started in 2025, is one of 6 observational ones, and was the 34th registered.

Osteoarthritis, Hip

642 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.

Browse Osteoarthritis, Hip studies →

Open to participants now

2 of the 34 studies in Osteoarthritis, Hip with a site in Denmark are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 86 Osteoarthritis, Hip studies recruiting now, 53 (62%) set no upper age limit and 7 (8%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Osteoarthritis, Hip with a site in Denmark, or all of them as a file.
02

Study summary

Patients with total hip or knee replacement experiencing persistant problems are offered 3 weeks of intensive rehabilitation.

Read the detailed description

Outcomes before, at the end of treatment and at 6 months follow up will be investigated. Data will be handled separately for the two groups of patients: 42 with a total hip replacement and 42 with a total knee replacement. Specific and generic outcomes will be collected.

03

Conditions studied

  • Hip Osteoarthritis
  • Knee Osteoarthristis

Keywords

  • total hip replacement
  • rehabilitation
  • hip osteoartritis
  • knee osteoarthritis
  • total knee replacement
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who have a total hip or knee replacement experiencing persistant problems, hence are admitted to a 3 week intensive rehabilitation period.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Patients with a total hip or knee replacement admitted for intensive rehabilitation

Exclusion criteria

Exclusion Criteria:

  • Patients unable to understand Danish
  • Unable to participate in physical tests
  • Unable to understand questionaires
  • Unable to participate i 6 months follow up
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
84 participants (estimated)
Patient registry
No

Groups and cohorts

  • Intervention group hip

    Patients with a total hip replacement undergoing rehabilitation

    Other: Rehabilitation

  • Intervention group knee

    Patients with a total hip replacement undergoing rehabilitation

    Other: Rehabilitation

Interventions

  • OtherRehabilitation

    Three weeks intensive rehabilitation where patients undergo group-based and individualised rehabilitation focusing at improving pain, function and quality of life for the patient

06

What researchers measure

Primary outcomes

  1. HOOS/KOOS pain (0-100 score)

    Hip or knee related pain

    Time frame: Change from baseline (0) to 3 weeks

  2. HOOS/KOOS ADL (0-100 score)

    Hip or knee related activities of daily living

    Time frame: Change from baseline (0) to 3 weeks

  3. HOOS/KOOS quality of life (0-100 score)

    Hip or knee related quality of life

    Time frame: Change from baseline (0) to 3 weeks

  4. HOOS/KOOS pain (0-100 score)

    Hip or knee related pain

    Time frame: Change from 3 weeks to 7 months

  5. HOOS/KOOS ADL (0-100 score)

    Hip or knee related activities of daily living

    Time frame: Change from 3 weeks to 7 months

  6. HOOS/KOOS quality of life (0-100 score)

    Hip or knee related quality of life

    Time frame: Change from 3 weeks to 7 months

  7. Sit-to-stand test

    Number of completed sit to stands in 30 seconds

    Time frame: Change from baseline (0) to 3 weeks

  8. Sit-to-stand test

    Number of completed sit to stands in 30 seconds

    Time frame: Change from 3 weeks to 7 months

Secondary outcomes

  1. Patient acceptable symptom state (yes/no)

    Patients are asked with a single question if their current symptom state is acceptable

    Time frame: 3 weeks follow up

  2. Patient acceptable symptom state (yes/no)

    Patients are asked with a single question if their current symptom state is acceptable

    Time frame: 7 months follow up

  3. Pain catastrophising scale (0-52 score)

    Current level of pain catastrophising with 0 being the best

    Time frame: Baseline

  4. Pain catastrophising scale (0-52 score)

    Current level of pain catastrophising with 0 being the best

    Time frame: 3 weeks

  5. Pain catastrophising scale (0-52 score)

    Current level of pain catastrophising with 0 being the best

    Time frame: 7 months

  6. Global rating of change (0-11 score)

    Likert scale where patients indicate their overall rating of change since the beginning of the intervention

    Time frame: Change from baseline to 3 weeks

  7. Global rating of change (0-11 score)

    Likert scale where patients indicate their overall rating of change since the beginning of the intervention

    Time frame: Change from baseline to 7 months

  8. The 5-level EQ-5D version (EQ-5D-5L) (0-5 scale)

    EQ5D5L scores

    Time frame: Change from baseline (0) to 3 weeks

  9. The 5-level EQ-5D version (EQ-5D-5L) (0-5 scale)

    EQ5D5L scores

    Time frame: Change from 3 weeks to 7 mothns

  10. EQ5D VAS (0-100 scale)

    EQ5D Vas overall health

    Time frame: Change from baseline (0) to 3 weeks

  11. EQ5D VAS (0-100 scale)

    EQ5D Vas overall health

    Time frame: Change from 3 weeks to 7 months

  12. HOOS/KOOS symptoms (0-100 score)

    Hip or knee related symptoms

    Time frame: Change from baseline (0) to 3 weeks

  13. HOOS/KOOS symptoms (0-100 score)

    Hip or knee symptoms

    Time frame: Change from 3 weeks to 7 months

  14. HOOS/KOOS sport/rec (0-100 score)

    Hip or knee related sport/rec

    Time frame: Change from baseline (0) to 3 weeks

  15. HOOS/KOOS sport/rec (0-100 score)

    Hip or knee related sport/rec

    Time frame: Change from 3 weeks to 7 months

  16. 6 minute walk test

    The distance a patient can walk in 6 minutes

    Time frame: Change from baseline (0) to 3 weeks

  17. 6 minute walk test

    The distance a patient can walk in 6 minutes

    Time frame: Change from 3 weeks to 7 months

  18. 40 meter fast paced walk test

    The time a patient uses walking 40 meters fast

    Time frame: Change from baseline (0) to 3 weeks

  19. 40 meter fast paced walk test

    The time a patient uses walking 40 meters fast

    Time frame: Change from 3 weeks to 7 months

  20. Stair test

    The time a patient uses to ascend and decend a staircase

    Time frame: Change from baseline (0) to 3 weeks

  21. Stair test

    The time a patient uses to ascend and decend a staircase

    Time frame: Change from 3 weeks to 7 months

Other outcomes

  1. Patient acceptable symptom state (yes/no)

    Patients are asked with a single question if their current symptom state is acceptable

    Time frame: Baseline

  2. Employment status (yes/no/part time)

    Time frame: Baseline

  3. Employment status (yes/no/part time)

    Time frame: 7 months

07

Study locations

1 of 1 sites recruiting
  • Horsens Regional Hospital
    Brædstrup, Denmark
    Recruiting
    • Signe Kierkegaard-Brøchner, PhD · Contactsignkier@rm.dk · 004578427882
    • Signe Kierkegaard-Brøchner, PhD · Principal investigator
    • Stian Langgård Jørgensen, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Dec 2027, 28 months after the start.

Of 52 non-industry observational studies under Osteoarthritis, Hip, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 59. This study's planned 28 months is above that.

Counting every sponsor, half of 81 studies reached it within 53 months; a quarter within 13 and three quarters within 113.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2025
First posted
Aug 6, 2025
StartActual
Aug 25, 2025
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Aug 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07105657
Lead sponsor
Horsens Hospital
Collaborators
VIA University College
Responsible party
Jeppe Lange (Ass. prof., Horsens Hospital) — Principal investigator
First posted
Aug 6, 2025
Start date
Aug 25, 2025
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Aug 26, 2025

Study contacts

Signe Kierkegaard-Brøchner, PhD
Contact
signkier@rm.dk
004578427882

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion